Lujun Zhao,Lvhua Wang. The progression in radiation therapy of lung cancer in China. Oncol Transl Med, 2015, 1: 5-14.
The progression in radiation therapy of lung cancer in China
Received:January 08, 2015  Revised:January 08, 2015
View Full Text  View/Add Comment  Download reader
KeyWord:lung cancer; radiation-induced lung toxicity; radiotherapy
Author NameAffiliationE-mail
Lujun Zhao Department of Radiation Oncology, Cancer Hospital and Institute Peking Union Medical College and Chinese Academy of Medical Science P.O. Box 2258, Beijing 100021, China. zhaolujun@tjmuch.com 
Lvhua Wang Department of Radiation Oncology, Cancer Hospital and Institute Peking Union Medical College and Chinese Academy of Medical Science P.O. Box 2258, Beijing 100021, China. wlhwq@yahoo.com 
Hits: 6458
Download times: 9047
Abstract:
      Lung cancer is the leading cause of death due to cancer in China. In recent years, great progress has been made in radiotherapy for lung cancer patients in China. The main advancements include the following aspects: (1) stereotactic ablative radiotherapy for early stage non-small cell lung cancer (NSCLC), (2) post-operative radiotherapy for NSCLC, (3) combined chemotherapy and radiotherapy for locally advanced NSCLC, (4) improved radiotherapy for advanced NSCLC, and 5) prediction of radiation-induced lung toxicity.
Close